Viemed Healthcare, Inc. SEC filings VMD

Viemed Healthcare, Inc. has 419 filings in SEC EDGAR's recent list, going back to Feb 1, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Viemed Healthcare, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 24, 2026 —
8-K Current report
Regulation FD disclosure
Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
S-8 Employee stock plan registration Aug 5, 2026 —
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 24, 2026 —
4 Insider transaction Jun 26, 2026 Jun 25, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure
Jun 2, 2026 Jun 2, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEF 14A Proxy statement Apr 22, 2026 Apr 22, 2026
DEFA14A Additional proxy material Apr 22, 2026 —
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
4 Insider transaction Mar 20, 2026 Mar 18, 2026
144 Notice of proposed sale Mar 20, 2026 —
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 18, 2026 —
8-K Current report
Regulation FD disclosure
Mar 16, 2026 Mar 16, 2026
10-K Annual report Mar 4, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Mar 4, 2026 Mar 4, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 19, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Nov 7, 2025 Nov 7, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2025 Sep 23, 2025
4 Insider transaction Aug 25, 2025 Aug 22, 2025
4 Insider transaction Aug 20, 2025 Aug 19, 2025
4 Insider transaction Aug 20, 2025 Aug 19, 2025
4 Insider transaction Aug 20, 2025 Aug 19, 2025
4 Insider transaction Aug 20, 2025 Aug 19, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4/A Form 4/a Aug 13, 2025 Jan 29, 2025
S-8 Employee stock plan registration Aug 12, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 15, 2025 —
8-K Current report
Regulation FD disclosure
Jul 2, 2025 Jul 2, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 1, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jun 9, 2025 Jun 6, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2025 Jun 5, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
8-K Current report
Regulation FD disclosure
May 6, 2025 May 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 29, 2025 —
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
8-K Current report
Officer or director change
Apr 14, 2025 Apr 14, 2025
8-K Current report
Regulation FD disclosure
Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
10-K Annual report Mar 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2024
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4/A Form 4/a Jan 23, 2025 Jan 18, 2025
4/A Form 4/a Jan 23, 2025 Jan 18, 2025
4/A Form 4/a Jan 23, 2025 Jan 18, 2025
4/A Form 4/a Jan 23, 2025 Jan 18, 2025
4/A Form 4/a Jan 23, 2025 Jan 18, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Nov 26, 2024 Nov 25, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 13, 2024 Nov 13, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 22, 2024 —
4 Insider transaction Aug 26, 2024 Aug 25, 2024
4 Insider transaction Aug 26, 2024 Aug 25, 2024
4 Insider transaction Aug 26, 2024 Aug 25, 2024
4 Insider transaction Aug 26, 2024 Aug 25, 2024
4 Insider transaction Aug 26, 2024 Aug 25, 2024
4 Insider transaction Aug 26, 2024 Aug 25, 2024
4 Insider transaction Aug 23, 2024 Aug 22, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
8-K Current report
Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
S-8 Employee stock plan registration Aug 12, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 6, 2024 Jun 6, 2024
8-K Current report
Material agreement, New debt
May 29, 2024 May 28, 2024
4 Insider transaction May 14, 2024 May 14, 2024
4 Insider transaction May 10, 2024 May 9, 2024
4 Insider transaction May 10, 2024 May 9, 2024
4 Insider transaction May 10, 2024 May 9, 2024
4 Insider transaction May 10, 2024 May 9, 2024
4 Insider transaction May 10, 2024 May 9, 2024
8-K Current report
Regulation FD disclosure
May 9, 2024 May 9, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 26, 2024 Apr 26, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
8-K Current report
Regulation FD disclosure
Apr 2, 2024 Apr 2, 2024
4 Insider transaction Mar 25, 2024 Mar 22, 2024
8-K Current report
Regulation FD disclosure
Mar 11, 2024 Mar 11, 2024
10-K Annual report Mar 6, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 6, 2024 Mar 6, 2024
SC 13D/A Amended ownership over 5% (active) Feb 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G Ownership over 5% (passive) Feb 2, 2024 —
4 Insider transaction Jan 30, 2024 Jan 29, 2024
4 Insider transaction Jan 30, 2024 Jan 29, 2024
4 Insider transaction Jan 30, 2024 Jan 29, 2024
4 Insider transaction Jan 30, 2024 Jan 29, 2024
4 Insider transaction Jan 30, 2024 Jan 29, 2024
4 Insider transaction Jan 30, 2024 Jan 29, 2024
4/A Form 4/a Jan 26, 2024 Jan 18, 2024
4/A Form 4/a Jan 26, 2024 Jan 18, 2024
4/A Form 4/a Jan 26, 2024 Jan 18, 2024
4/A Form 4/a Jan 26, 2024 Jan 17, 2024
4/A Form 4/a Jan 26, 2024 Jan 17, 2024
4/A Form 4/a Jan 26, 2024 Jan 17, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 22, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 7, 2023 Dec 7, 2023
3 Initial insider ownership Nov 9, 2023 Nov 8, 2023
8-K Current report
Regulation FD disclosure
Nov 8, 2023 Nov 7, 2023
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 1, 2023 Nov 1, 2023
EFFECT Filing Sep 6, 2023 —
CORRESP Letter to the SEC Aug 31, 2023 —
UPLOAD Letter from the SEC Aug 31, 2023 —
4 Insider transaction Aug 28, 2023 Aug 25, 2023
4 Insider transaction Aug 28, 2023 Aug 25, 2023
4 Insider transaction Aug 28, 2023 Aug 25, 2023
4 Insider transaction Aug 28, 2023 Aug 25, 2023
4 Insider transaction Aug 28, 2023 Aug 25, 2023
4 Insider transaction Aug 28, 2023 Aug 25, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
S-3 Shelf registration Aug 24, 2023 —
4 Insider transaction Aug 16, 2023 Aug 14, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
VMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Lafayette, LA
SEC filer status
Accelerated filer
SEC CIK
1729149

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.